JP2024521774A5 - - Google Patents

Info

Publication number
JP2024521774A5
JP2024521774A5 JP2023572737A JP2023572737A JP2024521774A5 JP 2024521774 A5 JP2024521774 A5 JP 2024521774A5 JP 2023572737 A JP2023572737 A JP 2023572737A JP 2023572737 A JP2023572737 A JP 2023572737A JP 2024521774 A5 JP2024521774 A5 JP 2024521774A5
Authority
JP
Japan
Prior art keywords
optionally substituted
membered
alkyl
hydrogen
bonded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023572737A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024521774A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/030823 external-priority patent/WO2022251292A1/en
Publication of JP2024521774A publication Critical patent/JP2024521774A/ja
Publication of JP2024521774A5 publication Critical patent/JP2024521774A5/ja
Pending legal-status Critical Current

Links

JP2023572737A 2021-05-25 2022-05-25 Rasの阻害方法 Pending JP2024521774A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163192837P 2021-05-25 2021-05-25
US63/192,837 2021-05-25
PCT/US2022/030823 WO2022251292A1 (en) 2021-05-25 2022-05-25 Methods for inhibiting ras

Publications (2)

Publication Number Publication Date
JP2024521774A JP2024521774A (ja) 2024-06-04
JP2024521774A5 true JP2024521774A5 (cg-RX-API-DMAC7.html) 2025-06-02

Family

ID=82115695

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023572737A Pending JP2024521774A (ja) 2021-05-25 2022-05-25 Rasの阻害方法

Country Status (11)

Country Link
US (1) US20240277796A1 (cg-RX-API-DMAC7.html)
EP (1) EP4346898A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024521774A (cg-RX-API-DMAC7.html)
KR (1) KR20240026526A (cg-RX-API-DMAC7.html)
CN (2) CN117715658A (cg-RX-API-DMAC7.html)
AU (1) AU2022281343A1 (cg-RX-API-DMAC7.html)
CA (1) CA3219533A1 (cg-RX-API-DMAC7.html)
IL (1) IL308771A (cg-RX-API-DMAC7.html)
MX (1) MX2023013912A (cg-RX-API-DMAC7.html)
TW (1) TW202313631A (cg-RX-API-DMAC7.html)
WO (1) WO2022251292A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022005359A (es) 2019-11-04 2022-06-02 Revolution Medicines Inc Inhibidores de ras.
IL301298A (en) 2020-09-15 2023-05-01 Revolution Medicines Inc Indole derivatives as RAS inhibitors in cancer therapy
IL308195A (en) 2021-05-05 2024-01-01 Revolution Medicines Inc RAS inhibitors for cancer treatment
AR127308A1 (es) 2021-10-08 2024-01-10 Revolution Medicines Inc Inhibidores ras
EP4463231A1 (en) * 2022-01-10 2024-11-20 Revolution Medicines, Inc. Ras inhibitors
WO2023232776A1 (en) * 2022-06-01 2023-12-07 F. Hoffmann-La Roche Ag Haloindole macrocyclic compounds for the treatment of cancer
EP4596552A1 (en) 2022-09-29 2025-08-06 Guangzhou Joyo Pharmatech Co., Ltd Macrocyclic derivative and use thereof
PE20252395A1 (es) 2023-02-14 2025-10-10 Hoffmann La Roche Compuestos triciclicos para el tratamiento de cancer
CN121487738A (zh) * 2023-03-30 2026-02-06 锐新医药公司 诱导ras gtp水解的组合物和其用途
TW202446387A (zh) * 2023-04-06 2024-12-01 瑞士商赫孚孟拉羅股份公司 用於治療癌症之三環化合物
KR20260019479A (ko) 2023-05-04 2026-02-10 레볼루션 메디슨즈, 인크. Ras 관련 질환 또는 장애를 위한 병용 요법
WO2025006967A1 (en) 2023-06-30 2025-01-02 Bristol-Myers Squibb Company Kras inhibitors
CN121693329A (zh) * 2023-07-14 2026-03-17 锐新医药公司 治疗ras相关疾病或病症的方法
WO2025162395A1 (zh) * 2024-02-01 2025-08-07 山东先声生物制药有限公司 吲哚衍生物作为ras抑制剂及其应用
CN119431325A (zh) * 2024-10-31 2025-02-14 诚达药业股份有限公司 一种3-(1h-吡唑-1-基)氮杂环丁烷类化合物及其合成方法
WO2026124659A1 (zh) * 2024-12-13 2026-06-18 苏州泽璟生物制药股份有限公司 二羰基类抑制剂及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL317393A (en) 2018-12-21 2025-02-01 Revolution Medicines Inc Compounds that participate in covalent bonds and their uses
DE102019122206B4 (de) 2019-08-19 2021-07-08 Webasto SE Dachmodul zur Bildung eines Fahrzeugdachs mit Umfeldsensor
CN121471132A (zh) 2019-11-04 2026-02-06 锐新医药公司 Ras抑制剂
MX2022005359A (es) 2019-11-04 2022-06-02 Revolution Medicines Inc Inhibidores de ras.
WO2021091956A1 (en) 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
IL301298A (en) 2020-09-15 2023-05-01 Revolution Medicines Inc Indole derivatives as RAS inhibitors in cancer therapy

Similar Documents

Publication Publication Date Title
JP2024512767A5 (cg-RX-API-DMAC7.html)
JP6193922B2 (ja) ハロアルキルヘテロアリールベンズアミド化合物
JP2024521920A5 (cg-RX-API-DMAC7.html)
JP2010501478A5 (cg-RX-API-DMAC7.html)
JP2023515617A5 (cg-RX-API-DMAC7.html)
JP2011527334A5 (cg-RX-API-DMAC7.html)
JP2009537546A5 (cg-RX-API-DMAC7.html)
JP2023529908A5 (cg-RX-API-DMAC7.html)
JP2025510074A5 (cg-RX-API-DMAC7.html)
JP2008510828A5 (cg-RX-API-DMAC7.html)
JP2023545274A5 (cg-RX-API-DMAC7.html)
JP2023515618A5 (cg-RX-API-DMAC7.html)
US20120108592A1 (en) Pharmaceutical compositions and methods of use of salicylanilides for treatment of hepatitis viruses
CA2437524A1 (en) Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
JP2006500370A5 (cg-RX-API-DMAC7.html)
TW200911239A (en) Alkylsulfonyl-substituted thiazolide compounds
CA2494832A1 (en) Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
JP2009500423A5 (cg-RX-API-DMAC7.html)
JP2010540666A5 (cg-RX-API-DMAC7.html)
JP2024520395A5 (cg-RX-API-DMAC7.html)
JP2021523109A5 (cg-RX-API-DMAC7.html)
JP2008502670A5 (cg-RX-API-DMAC7.html)
JP2005527542A5 (cg-RX-API-DMAC7.html)
JP2005517643A5 (cg-RX-API-DMAC7.html)
WO2013071694A1 (zh) 噁唑类化合物及其制备方法、药物组合物及其用途